Home › NCT07288047
Virtual Reality as a Method for Pain and Anxiety Control During First Trimester Procedural Abortion
Virtual Reality as an Adjunctive Agent for the Management of Pain and Anxiety During First Trimester Procedural Abortion: a Randomized Controlled Trial
Who can join
Ages 18 and older · Women
Full eligibility criteria
Inclusion Criteria: * Patients at Planned Parenthood of Western Pennsylvania who have decided to undergo and are eligible for a procedural abortion. * 18 years old or older * \<14 weeks gestation on day of abortion * Able to comprehend written English * Willing to comply with the study protocol * Willing and able to provide informed consent Exclusion Criteria: * History of vertigo * History of epilepsy * Claustrophobia * Significant hearing or visual impairments (such as deafness or blindness) * Require hearing aids * Have an implanted medical device, such as cardiac pacemaker or defibrillator * Require misoprostol for cervical preparation * Prior unsuccessful attempt at abortion during this pregnancy
About the study
The goal of this clinical trial is to learn whether use of a virtual reality (VR) headset showing a meditative nature video will help reduce pain and anxiety during a first trimester procedural abortion. Investigators will enroll 72 patients undergoing a first trimester procedural abortion with usual care to manage pain and anxiety compared to use of a VR headset in addition to usual care to see if use of the VR headset will decrease pain and anxiety and increase satisfaction with the procedure.
What is being tested
- VR headset (device)
- Usual Care (other)
Sponsor: Study Investigator · Participants: 72 · Started: May 1, 2026
Contact the study team
- Study Coordinator · Phone: 412-641-5496
Official record on ClinicalTrials.gov — NCT07288047
Locations in the U.S.
| Pennsylvania | Center for Family Planning Research, Magee-Womens Hospital, Pittsburgh Planned Parenthood of Western Pennsylvania, Pittsburgh |
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.